Ashland Inc. (ASH) Q3 2026 Earnings
As seen on the 24/7 Wall St. homepage on July 28, 2026.
Q3 2026
EPS
$1.02
est $0.98
+3.6%
Revenue
$497M
est $486M
+2.3%
Ashland beat on both lines with EPS of $1.02 and revenue of $497 million, driven by 6% volume growth across all segments and pharma's fifth consecutive quarter of gains, but the company downgraded its annual EPS outlook to low-to-mid-single-digit growth from mid-to-high due to tax headwinds.
Mentioned: ASH